Raw Cetilistat powder is a novel pancreatic lipase inhibitor developed by Alizyme for the treatment of obesity and diabetes and other diseases. It acts by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the gut. Prevents fat (triglycerides) in food from being metabolized and converted into free fatty acids that can be absorbed by the body. Raw Cetilistat powder significantly reduced weight with and was better tolerated than orlistat.
ຜົງ Raw Cetilistat ແມ່ນຢາຕ້ານເຊື້ອ lipase pancreatic novel ທີ່ພັດທະນາໂດຍ Alizyme ສໍາລັບການປິ່ນປົວຂອງໂລກອ້ວນແລະພະຍາດເບົາຫວານແລະພະຍາດອື່ນໆ. ມັນປະຕິບັດໂດຍ inhibiting lipase pancreatic, enzyme ທີ່ທໍາລາຍລົງ triglycerides ໃນລໍາໄສ້. ການປ້ອງກັນໄຂມັນ (triglycerides) ໃນອາຫານຈາກການໄດ້ຮັບການແລກປ່ຽນແລະປ່ຽນເປັນກົດໄຂມັນຟຣີທີ່ສາມາດດູດຊືມຈາກຮ່າງກາຍ. ຜົງ Raw Cetilistat ໄດ້ຫຼຸດລົງຢ່າງຫຼວງຫຼາຍນ້ໍາທີ່ມີແລະໄດ້ດີກວ່າ tolerated ກວ່າ orlistat.